Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy

Abroad (travel likely)Recruiting

Conditions

Hematologic Malignancy · Blood Cancer · Lymphoma · Leukemia · Multiple Myeloma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Contact: Study coordinator (Patrick C Johnson, MD) · PCJOHNSON@MGH.HARVARD.EDU · 617-724-4000

Study leads

Patrick C Johnson, MD
Principal Investigator
Massachusetts General Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

Recurrent Chronic Lymphocytic Leukemia · Recurrent Small Lymphocytic Lymphoma · Refractory Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children

Adrenal Insufficiency · Leukemia, Lymphoblastic, Acute, Pediatric · Lymphoma, Lymphoblastic

Abroad (travel likely)Recruiting

Aarau, Switzerland · Basel, Switzerland

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

Acute Myelogenous Leukemia · Acute Lymphatic Leukemia · Chronic Myelogenous Leukemia

Abroad (travel likely)RecruitingPHASE2

Cleveland, United States

A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Relapsed/Refractory Multiple Myeloma

Abroad (travel likely)RecruitingPHASE1

Parkville, Australia